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We recently derived mouse expanded potential stem cells (EPSCs) from individual 
blastomeres by inhibiting the critical molecular pathways that predispose their 
differentiation1. EPSCs had enriched molecular signatures of blastomeres and 
possessed the developmental potency for all embryonic and extraembryonic cell 
lineages. Here, we report the derivation of porcine EPSCs, which express key 
pluripotency genes, are genetically stable, permit genome editing, differentiate to 
derivatives of the three germ layers in chimeras, and produce primordial germ cell-
like cells in vitro. Under similar conditions, human ESCs and iPSCs can be converted, 
or somatic cells directly reprogrammed, to EPSCs that display the molecular and 
functional attributes reminiscent of porcine EPSCs. Significantly, trophoblast stem 
cell-like cells can be generated from both human and porcine EPSCs. Our pathway-
inhibition paradigm thus opens a new avenue for generating mammalian pluripotent 
stem cells, and EPSCs present an unique cellular platform for translational research in 
biotechnology and regenerative medicine.   
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Mouse and human embryonic stem cells (ESCs) that derived from preimplantation 
embryos2-4 self-renew in long term cultures and differentiate to all embryonic cell 
lineages in vitro and in mouse chimeras. The development of well-defined culture 
conditions such as 2i/LIF has substantially facilitated derivation and maintenance of 
mouse ESCs5, and led to intensive efforts for deriving human ESCs akin to mouse 
ESCs6,7. It has however been challenging to translate the findings in studying mouse 
and human cells to establishing ESCs from other mammalian species. The domestic 
pig shares great genetic, anatomical and physiological similarities with humans, and is 
considered to be an excellent model for human diseases, cell therapies and even as 
donor for porcine xenografts. To this date, bona fide porcine ESCs have yet to be 
established.8-15 The published lines usually do not meet with the stringent criteria for 
pluripotency and are frequently called “ES-like” cells.  
We have recently demonstrated that by targeting key molecular pathways that drive 
lineage differentiation in the mouse preimplantation embryo, expanded potential stem 
cells (mEPSCs) displaying a broad propensity for extraembryonic and embryonic 
lineage differentiation were derived1,16. We hypothesized that a similar experimental 
paradigm of targeting key developmental pathways might be applied for establishing 
porcine stem cells from preimplantation embryos. However, little is known about the 
molecular and signalling mechanisms of porcine early preimplantation embryo 
development, we thus set out to perform a chemical screen of inhibitors that were 
used for isolating and maintaining mouse mEPSCs, mouse and human ESCs and to 
delineate the optimal condition for porcine cells. Our results demonstrate that porcine 
EPSCs could be established, and that significantly, similar culture conditions permit 
derivation of human EPSCs. 
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Results and Discussion 
Identification of culture conditions for porcine pluripotent stem cells 
While porcine iPSCs are available, their use for the screen is confounded by the leaky 
expression of the transgenic reprogramming factors after reprogramming or by low 
levels of expression of the endogenous pluripotency genes17-20. To overcome this 
challenge, we generated new porcine iPSCs by expressing Doxycycline (Dox)-
inducible eight transcription factors, which substantially improved the efficiency of 
reprogramming wild-type and transgenic porcine fetal fibroblasts (PFFs), in which a 
tdTomato cassette had been inserted into the 3’ UTR of the porcine OCT4 (POU5F1) 
locus (POT PFFs)21, to putative iPSC colonies (Fig. 1a-c). The iPSCs from POT PFFs 
were OCT4-tdTomato+, (Fig. 1c), and expressed high levels of the endogenous 
pluripotency factors (Fig. 1d).  iPSCs could be passaged as single cells for more than 
20 passages in serum-containing medium (M15) plus Dox. Upon Dox removal, the 
iPSCs differentiated within 4-5 days, concomitant with rapid down-regulation of the 
exogenous reprogramming factors and endogenous pluripotency genes and with 
increased expression of both embryonic and extraembryonic cell lineage genes (Fig. 
1e-h). These Dox-dependent iPSCs with robust endogenous pluripotency gene 
expression provided the material for the chemical screen.   
In the screen, over 400 combinations of 20 small molecule inhibitors and cytokines 
were tested for their ability to maintain Dox-independent porcine iPSCs in the 
undifferentiated state (Fig. 1i; Supplementary Table 1). A departure was noted from 
previous reports that naïve mouse ESC medium 2i/LIF5 was able to maintain putative 
porcine iPSCs22-24: Porcine iPSCs were rapidly lost with 1.0M Mek1 inhibitor PD-
0325901, irrespective of whether Dox was present or not  (Extended Data Fig. 1a-g), 
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indicating that porcine pluripotent stem cells differ from mouse ESCs in the 
requirement of Mek-ERK signalling5,25. Inhibition of p38 and PKC was also non-
conducive for porcine iPSCs (Extended Data Fig. 1f and 1h). Therefore mouse or 
human naïve ESC conditions5-7 cannot be directly extrapolated to porcine cells. The 
inhibitors for Mek1/2, p38 and PKC were therefore excluded from the screen. Several 
conditions were identified that met the screen criteria (Extended Data Fig. 1g), 
including a minimal requisite condition (#517, porcine EPSC medium: pEPSCM) 
comprising inhibitors for GSK3 (CHIR99021), SRC (WH-4-023) and Tankyrases 
(XAV939) (the last two were inhibitors important for mouse EPSCs1) , and 
supplements: Vitamin C (Vc), ACTIVIN A and LIF (Fig. 1i. and Extended Data Fig. 
1g and Supplementary Table 1). Under these conditions, the Dox-independent iPSCs 
(pEPSCiPS) remained undifferentiated in 30 passages, expressed endogenous 
pluripotency factors at levels comparable to the porcine blastocyst and showed no 
leaky expression of the exogenous reprogramming factors (Fig. 1j, and Extended Data 
Fig. 1i-j).  
We next repeated the reprogramming experiment by directly culturing the primary 
colonies in pEPSCM (Extended Data Fig. 2a), and generated 11 stable pEPSCiPS lines 
from 16 primary colonies (70% efficiency) with six of them having no detectable 
expression of any of the eight exogenous reprogramming factors but high levels of 
endogenous pluripotency genes (Extended Data Fig. 2b).  
Establishment of porcine EPSCs from preimplantation embryos  
The pEPSCM condition was subsequently employed to derive stem cell lines from 
porcine preimplantation embryos. A total of 26 lines (pEPSCsEmb, 14 male and 12 
female) were established from 76 early blastocysts (5.0 dpc), and 12 cell lines 
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(pEPSCspar) from 252 parthenogenetic blastocysts (Fig. 2a, Supplementary Table 2 
and Extended Data Fig. 2c). Similar to pEPSCsiPS, pEPSCsEmb had high 
nuclear/cytoplasmic ratios, and formed compact colonies with smooth colony edges 
(Fig. 2a, Extended Data Fig. 2d).  pEPSCsEmb were passaged every 3-4 days at 1:8 
ratio as single cells, could be maintained for >40 passages on STO feeders without 
overt differentiation and were genetically stable (Extended Data Fig. 2e). Subcloning 
efficiency was about 10% at low cell density (2,000 cells per well in a 6-well plate), 
but routine passaging was performed at high cell density.  
Pluripotency genes were expressed in pEPSCsEmb and pEPSCsiPS at levels comparable 
to the blastocysts (Fig. 2b and Extended Data Fig. 2b), but were drastically reduced or 
lost when pEPSCs were cultured in other porcine ESC media previously reported 9-15 
(Extended Data Fig. 2f-g). pEPSCs showed extensive DNA demethylation at the 
OCT4 and NANOG promoter regions (Fig. 2c) and had OCT4 distal enhancer activity 
(Extended Data Fig. 2h). pEPSCs were amenable for Crispr/Cas9-mediated insertion 
of an H2B-mCherry expression cassette into the ROSA26 locus (Extended Data Fig. 2i 
and 2j). In vitro, pEPSCs differentiated to tissues expressing genes representative of 
the three germ layers and, uniquely, trophoblast genes (Fig. 2d, Extended Data Fig. 
2k). In immunocompromised mice, pEPSCsEmb formed mature teratomas with 
derivatives of the three germ layers, and contained placental lactogen-1 (PL-1)-, 
KRT7- and SDC1-positive trophoblast-like cells (Fig. 2e-2f). Following incorporation 
of the pEPSCs into preimplantation embryos and after 48 hours of culture, pEPSCs 
(marked by H2B-mCherry) had colonized both the trophectoderm and inner cell mass 
of blastocysts (Extended Data Fig. 3a). Following transfer of the chimeric blastocysts 
to synchronized recipient sows, a total of 45 conceptuses were harvested from 3 litters 
at days 26-28 of gestation (Supplementary Table 3, Extended Data Fig. 3b). Flow 
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cytometry analysis of dissociated cells from embryonic and extraembryonic tissues of 
the chimeras detected mCherry+ cells in 7 conceptuses (Extended Data Fig. 3c, 
Supplementary Table 4 and Table 5): mCherry+ cells in both the placenta and 
embryonic tissues in 2 chimeras (#8 and #16); only in embryonic tissues in 3 
chimeras (#4, #21 and #34); and exclusively in the placenta of 2 chimeras (#3 and 
#6). Genomic DNA PCR assays detected mCherry DNA only in those seven 
mCherry+ chimeras, but not in any other conceptuses (Extended Data Fig. 3d, 
Supplementary Table 4 and 5). Despite the low contribution of the donor mCherry+ 
cells, their descendants were found in multiple embryonic tissues and organs that 
were identified by tissue lineage markers (Fig. 2g  and Extended Data Fig. 3e-f). 
Therefore, pEPSCsEmb and pEPSCsiPS, like mEPSCs, possess an expanded 
developmental potential for both the embryonic cell lineages and extra-embryonic 
trophoblast lineages. 
Derivation of PGC-like cells (PGCLCs) from pEPSCsEmb 
We next asked if pEPSCs had the potential to produce PGCLCs in vitro, similar to 
mouse and human pluripotent stem cells26-28. In early-primitive streak (PS)-stage 
porcine embryos (E11.5–E12), the first cluster of porcine PGCs can be detected as 
SOX17+ cells in the posterior end of the nascent primitive streak, and these cells later 
co-express OCT4, NANOG, BLIMP1 and TFAP2C28. NANOS3 is an evolutionarily 
conserved PGC-specific factor29,30 and human NANOS3 reporter ESCs have been 
used for studying the derivation of PGCLCs27,28. We generated and used a NANOS3-
H2B-mCherry pEPSCEmb reporter line to facilitate identification of putative PGCLCs 
(Extended Data Fig. 4a). After expressing the SOX17 transgene transiently for 12 
hours, the reporter cells were allowed to form embryoid bodies (EBs) (Extended Data 
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Fig. 4b), where cell clusters co-expressing NANOS3 (mCherry+) and tissue-
nonspecific alkaline phosphatase (TNAP, a PGC marker) were detected within 3-4 
days (Fig. 3a).  
The derivation of putative porcine PGCLCs was BMP2/4 dependent (Fig. 3a). 
Interestingly, different from the reported derivation of human PGCLCs28, expressing 
NANOG, BLIMP1 or TFAP2C transgenes, either individually or in combination, had 
no effect on the preponderance of NANOS3+ cells (Extended Data Fig. 4c), whereas 
co-expression of SOX17 with BLIMP1 appeared to increase NANOS3+ cells 
(Extended Data Fig. 4c and 4d).  
The putative PGCLCs within the EBs expressed PGC-specific genes (Fig. 3b-c, and 
Extended Data Fig. 4e). Specific RNA-seq analysis of NANOS3+ cells revealed 
expression of early PGC genes27 (OCT4, NANOG, LIN28A, TFAP2C, CD38, DND1, 
NANOS3, ITGB3, SOX15 and KIT), and reduced SOX2 expression (Fig. 3d-e). Similar 
to PGCLC derivation from human ESCs27, DNMT3B was down-regulated in porcine 
mCherry+/NANOS3+ cells whereas TET1/2 were up-regulated, relative to the parental 
pEPSCsEmb (Fig. 3e-f).  
Establishment of human EPSCs under conditions similar to porcine EPSCs 
The finding that inhibition of SRC and Tankyrases is sufficient to convert mouse 
ESCs to mEPSCs1 and that the same two inhibitors are required for the derivation of 
pEPSCs raises the possibility that similar in vitro culture conditions may be 
developed for additional mammalian species. To explore this possibility, we cultured 
four established human ES cell (hESC) lines (H1, H9, Man1/M1, and Man10/M10 
cells)4,31,32 in pEPSCM and passaged them three times. The cells displayed diverse 
morphologies and heterogeneous expression of OCT4 (Extended Data Fig. 5a). 
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Removing ACTIVIN A (20.0 ng/ml) from pEPSCM led to considerably fewer cell 
colonies formed from H1 (<1.0%) and M1 (5.0%) ESCs, while none from H9 or M10 
(Extended Data Fig. 5a), which reflects the inherent between-line heterogeneity of 
human ESCs33,34. With further refinement of the culture conditions (for example, 
replacing WH-4-023 with another SRC inhibitor A419259 in hEPSCM, see Methods), 
morphologically homogenous and stable cell lines were established from single-cell 
sub-cloned H1 (H1-EPSCs) and M1 cells (M1-EPSCs) (Fig. 4a). Karyotype analysis 
of H1 and M1 cells grown in hEPSCM on STO feeders revealed genetic stability (at 
passage 25 post conversion from the parental hESCs, Extended Data Fig. 5b). When 
human primary iPSC colonies reprogrammed from fibroblasts were directly cultured 
in hEPSCM, around 70% of the picked colonies could be established as stable iPSC 
lines (iPSC-EPSCs) (Extended Data Fig. 5c), which expressed pluripotency markers 
with no obvious leakiness of the exogenous reprogramming factors in about half of 
the lines (Fig. 4b and Extended Data Fig. 5d). The H1-EPSCs proliferated more 
robustly than the H1 ESCs cultured in standard FGF-containing medium (H1-ESC, 
primed) or under naïve 5i/L/A conditions (H1-naïve ESC)7 (Extended Data Fig. 5e), 
and were tolerant of single cell passaging with about 10% single cell sub-cloning 
efficiency in the transient presence of ROCKi. Cell survival at passaging was 
substantially improved in the presence of 5.0ng/ml ACTIVIN A or by splitting the 
cells at higher density. Human EPSCs expressed pluripotency genes at higher levels 
than the H1-ESCs (Fig. 4b) and minimal levels of lineage markers (Extended Data 
Fig. 5f). Expression of core pluripotency factors and surface markers in human 
EPSCs was confirmed by immunostaining (Extended Data Fig. 5g). H1-EPSCs 
differentiated to derivatives of the three germ layers in vitro and in vivo (Extended 
Data Fig. 5h-i). Moreover, H1-EPSCs were successfully differentiated to PGCLCs 
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using in vitro conditions developed for germ cell competent hESCs or iPSCs27,28 (Fig. 
4c and Extended Data Fig. 5j).  
Our results demonstrate that porcine and human EPSCs could be derived and 
maintained using the similar set of small molecule inhibitors. Global gene expression 
profiling revealed that pEPSCs and hEPSCs were clustered together, and were distinct 
from PFFs or other human pluripotent stem cells1,35,36 (Fig. 4d-e). Both porcine and 
human EPSCs expressed high levels of key pluripotency genes, low levels of somatic 
cell lineage genes, PAX6, T, GATA4 and SOX7, or placenta-related genes (PGF, 
TFAP2C, EGFR, SDC1 and ITGA5) (Extended Data Fig. 6a-d). Consistent with the 
high levels of global DNA methylation of pEPSCs and hEPSCs (Extended Data Fig. 
6e), DNA methyltransferase genes DNMT1 and DNMT3A and DNMT3B were highly 
expressed, whereas TET1, TET2 and TET3 were expressed at lower levels (Extended 
Data Fig. 6f-g). Among the highly expressed 76 genes (>8-fold increase) in H1-EPSC 
in comparison to H1-ESCs, 17 genes encode histone variants with 15 belonging to the 
histone cluster 1 (Fig. 4f and Supplementary Table 6). nterestingly, these histone 
genes were expressed at low levels in 5i and primed human ESCs but were highly 
expressed in human 8-cell and morula stage embryos (Fig. 4g). The significantly 
higher expression of these histone genes was confirmed in additional hEPSC lines 
(Fig. 4h). The biological significance of this observation remains to be investigated.  
Single cell RNA-seq (scRNAseq) reveals substantially homogenous EPSC 
cultures 
EPSCs expressed uniform levels of the core pluripotency factors (Fig. 5a) and were 
generally homogenous cells in culture in the context of single-cell transcriptome (Fig. 
5b). Mouse EPSCs had enriched transcriptomic features of 4-cell to 8-cell 
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blastomeres1.  scRNAseq analysis suggested that hEPSCs were transcriptionally, as 
well as the histone gene expression profiles, more similar to human 8-cell to morula 
stage embryos37,38 than other stages of preimplantation embryos (Fig. 5c, and 
Extended Data Figure 6h; Fig. 4g-hand Extended Data Fig. 6i). Interestingly, single-
cell transcriptome also revealed low expression of naïve pluripotency factors such as 
KLF2 in EPSCs (Fig. 5a and Extended Data Fig. 6a-b), which is also not highly 
expressed in human early preimplantation embryos39. Although KLF2, TET1, TET2 
and TET3 were weakly expressed in both pEPSCs and hEPSCs (Extended Data Fig. 
6a-b and 6f-g), their promoter regions were characterized by active H3K4m3 histone 
marks (Fig. 5d-e). In contrast to pluripotency genes, in both porcine and human 
EPSCs, the cell lineage gene loci (e.g. CDX2, GATA2, GATA4, SOX7 and PDX1) had 
high H3K27me3 and low H3K4me3 marks, respectively (Fig. 5e).  
Human and porcine EPSCs have similar signalling requirements 
To identify signalling requirements in EPSCs, we removed individual components 
from the culture medium. Removal of the SRC inhibitor WH-4-023 or A419259 
reduced expression of pluripotency factors in both EPSCs (Fig. 6a-d). Notably, in 
hEPSCs, using the SRC inhibitor WH-4-023 instead of A419259 led to lower 
pluripotency gene expression (Fig. 6b). Similar to mEPSCs, XAV939 enhanced 
AXIN1 protein content (Fig. 6e), and reduced canonical WNT activities in both 
EPSCs (Fig. 6f). Withdrawal of XAV939 caused collapse of pluripotency and 
differentiation of these EPSCs (Fig. 6a-b, 6d, and 6g-k). SMAD2/3 were 
phosphorylated in EPSCs (Fig. 6e). Either removing ACTIVIN A from pEPSCM or 
adding the TGFβ inhibitor SB431542 resulted in massive cell loss and down-
regulation of pluripotency factors in pEPSCs (Fig. 6a, 6g, 6h and 6j). hEPSCs did not 
require exogenous TGFB in culture but inhibiting TGFβ induced rapid cell 
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differentiation with preferential expression of trophoblast genes CDX2, ELF5 and 
GATA2 (Fig. 6b, 6i and 6k). At a relatively low concentration of ACTIVIN A 
(5.0ng/ml), hEPSCs showed a stronger propensity for embryonic mesendoderm 
lineage differentiation (Fig. 6l) and generated more NANOS3-tdTomato+ PGCLCs 
(Fig. 6m-n). Removing CHIR99021 and Vitamin C from EPSCM did not affect 
pluripotency gene expression but reduced the number of colonies formed from single 
cells (Fig. 6a-b and 6h-i), whereas a high CHIR99021 concentration (3.0µM) induced 
differentiation of both EPSCs (Fig. 6a, 6h and 6j), similar to that in human or rat 
naïve cells6,40. JNK and BRAF inhibition might improve culture efficiency but was 
not essential (Fig. 6h-i). Mouse naïve ESCs is cultured 1.0M Mek1/2 inhibitor 
PD0325901 (Ref. 5). We noticed that even 0.1 µM PD0325901 decreased pEPSC 
survival as measured by colony formation in serial passaging (Fig. 6h).  
 
hEPSCs have potent potential to trophoblasts 
We further investigated differentiation of hEPSCs to trophoblasts by generating the 
CDX2-Venus reporter line (Extended Data Fig. 7a). Inhibiting TGF by SB431542 
resulted in ~70% of the reporter cells being CDX2-Venus+ (Fig. 7a), whereas 
essentially no CDX2-Venus+ cells were detected if the reporter cells were previously 
cultured in FGF or under the 5i naïve ESC conditions. Consistently, trophoblast gene 
levels were rapidly increased in differentiated H1-EPSCs and iPSC-EPSCs but not in 
H1-ESCs or H1-5i naïve cells (Fig. 7b). Addition of BMP4, which promotes 
differentiation of human ESCs to putative trophoblasts41, induced a much higher level 
of expression of trophoblast genes in EPSCs than in H1-ESCs or H1-5i naïve ESCs 
(Extended Data Fig. 7b). Inhibiting FGF and TGF signalling while in parallel 
activating BMP4 was reported to effectively induce trophoblast differentiation of 
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human ESCs42,43. Under these conditions, expression of trophoblast genes, especially 
the late trophoblast genes GCM1, CGA and CGB, was much higher in H1-EPSCs than 
in H1-ESCs, whereas naïve 5i hESCs displayed no sign of trophoblast differentiation 
(Extended Data Fig. 7c). Global gene expression analysis demonstrated that under 
TGF signalling inhibition H1-EPSCs and iPSC-EPSCs followed a differentiation 
trajectory distinct from that of H1-ESCs (Fig. 7c), and that in cells differentiated from 
EPSCs, but not from H1-ESCs, genes associated with trophoblast development or 
function were highly expressed including: (1) BMP4 (Day 2-4); (2) Syncytin-1 
(ERVW-1) and Syncytin-2 (ERVFRD-1) that promote cytotrophoblast fusion into 
syncytiotrophoblast; (3) p57 (encoded by CDKN1C) 44,45; (4) CD274 (encoding PD-
L1 or B7-H1); and (5) EGFR46 (Fig. 7d).    
We next performed Pearson correlation coefficient analysis of the transcriptome of 
cells differentiated under TGF inhibition with published reference data of primary 
human trophoblasts (PHTs) and human placenta tissues43, which again revealed the 
similarity between cells differentiated from hEPSCs and PHTs and the placenta 
(Extended Data Fig. 7d). The differentiated cells from H1-EPSCs expressed human 
trophoblast specific miRNAs (C19MC miRNAs: hsa-miR-525-3p, hsa-miR-526b-3p, 
hsa-miR-517-5p, and hsa-miR-517b-3p)47 (Extended Data Fig. 7e-f), displayed DNA 
demethylation at the ELF5 locus48,49 (Fig. 7e), and produced abundant amounts of 
placental hormones (Fig. 7f-g).  
One key mechanism for derivation and maintenance of EPSCs of mouse, porcine and 
human is blocking poly(ADP-ribosyl)ation activities of PARP family members 
TNKS1/2 using small molecule inhibitors such as XAV93950,51. In human cells, 
poly(ADP-ribose) in proteins is removed by poly(ADP-ribose) glycohydrolase 
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(PARG) and ADP-ribosylhydrolase 3 (ARH3)52. Genetic inactivation of Parp1/2 and 
TNKS1/2 in the mouse caused trophoblast phenotypes53, whereas inactivating Parg 
led to loss of functional trophectoderm and trophoblast stem cell (TSCs)54. In 
hEPSCs, PARG-deficiency did not appear to cause noticeable changes in EPSCs but 
adversely affected trophoblast differentiation (Extended Data Fig. 7g-j), which may 
indicate an evolutionally conserved mechanism for EPSCs and trophoblast 
development between mouse and human.  
Derivation of TSC-like cells from human and porcine EPSCs 
When hEPSCs (ESC-converted-EPSCs and iPSC-EPSCs) were cultured in human 
TSC conditions46 with low cell density (2,000 cells/3.5cm dish), colonies with TSC 
morphology formed after 7-9 days (Fig. 8a). These colonies were picked and 
expanded into stable cell lines under TSC conditions with up to 30% efficiency in line 
establishment. These hEPSC-derived TSC-like cells were referred in this study as 
hTSCs.  In contrast, no lines were established from human H1 or M1 ESCs under the 
hTSC condition, whether they were originally cultured under primed or naïve ESCs 
conditions. The hTSCs expressed trophoblast transcription regulators: GATA3 and 
TFAP2C but had down-regulated pluripotency genes (Fig. 8b-c), and showed 
enriched transcriptomic features of day-4 differentiated human EPSCs under TGF 
inhibition (Fig. 8d). Following the published protocols46, we were able to differentiate 
hTSCs to multi-nucleated syncytiotrophoblasts (ST) and HLA-G+ extravillous 
trophoblasts (EVT) (Fig. 8e-i). Once injected into immunocompromised mice, hTSCs 
formed lesions with cells positively stained for SDC1 and KRT7 (Fig. 8j-k). 
Additionally, high levels of hCG were detected in blood of the mice with hTSC-
lesions but not in control mice injected with vehicle only (Fig.8l). Although neither 
EPSCs expressed high levels of placenta development-related genes (Extended Data 
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Fig. 6c-d), both displayed enriched H3K4me3 at these loci (Extended Data Fig. 8a), 
clearly underpinning EPSCs’ trophoblast potency. Under hTSC conditions, stable 
TSC-like lines could also be derived from pEPSCsEmb (pTSCs). Extended Data Fig. 
8b). pTSCs were similar to hTSCs in gene expression profiles and the propensity of 
lesion formation in immunocompromised mice (Extended Data Fig. 8c-f). When 
introduced into porcine preimplantation embryos, descendants of pTSCs were found 
in the trophectoderm and expressed GATA3 and CDX2 (Extended Data Fig. 8g). Our 
results therefore provide compelling evidence that human and porcine EPSCs 
possessed expanded potential that encompasses the trophoblast lineage.  
 
In conclusion, EPSCs of mouse, pig and human can now be established under similar 
in vitro culture conditions. These stem cells share common molecular features and 
possess expanded potency for both embryonic and extraembryonic cell lineages that 
are generally not seen in the conventional embryo-derived or induced pluripotent stem 
cells. EPSCs therefore represents a unique state of cellular potency. The successful 
generation of EPSCs produces new tools for investigation of embryonic development 
and opens new avenues for translational research in biotechnology, agriculture, and 
genomics and regenerative medicine. 
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Figure 1. Identification of culture conditions for porcine EPSCs. a. Doxycycline 
(Dox)-inducible expression of Yamanaka factors OCT4, MYC, SOX2 and KLF4, 
together with LIN28, NANOG, LRH1 and RARG in porcine PFFs. Stable genomic 
integration of cDNAs in PFFs was achieved by piggyBac transposition. pOMSK: 
Porcine OCT4, MYC, SOX2 and KLF4; pN+hLIN: porcine NANOG and human 
LIN28; hRL: human RARG and LRH1. The reprogrammed colonies were single-cell 
passaged in the presence of Dox in M15 (15% fetal calf serum). b. Co-expression of 
LIN28, NANOG, LRH1 and RARG substantially increased the number of 
reprogrammed colonies from 250,000 PFFs (n = 4 independent experiments). c. 
Reprogramming of the porcine OCT4-tdTomato knock-in reporter (POT) TAIHU and 
wide type (WT) German Landrace PFFs to iPSCs. d. The iPSCs lines expressed key 
pluripotency genes in RT-qPCR analysis. The iPSC lines #1 and #2, and iPSC #3 and 
#4 were from WT German Landrace and POT PFFs, respectively. e. RT-qPCR 
analysis of the exogenous reprogramming factors in iPSCs either in the presence of 
Dox or 5 days after its removal. f. POT iPSCs became Td-tomato negative 5 days 
after Dox removal. g. RT-qPCR analysis of the expression of endogenous 
pluripotency genes in iPSCs cultured with or without Dox. h. Expression of lineage 
genes in porcine iPSCs 5-6 days after DOX removal. Gene expression was measured 
by RT-qPCR. Relative expression levels are shown with normalization to GAPDH. 
Experiments were performed 3 times. i. Diagram depicting the screen strategy for 
identifying culture conditions for porcine pluripotent stem cells using the Dox-
dependent iPSC. Small molecule inhibitors and cytokines were selected for various 
combinations. Cell survival, cell morphology, and expression of endogenous OCT4 
and NANOG were employed as the read-outs. j. Images of OCT4-Tdtomato reporter 
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(POT) iPSCs in pEPSCM without Dox. In all RT-qPCR analysis, n=3 independent 
experiments. All graphs represent the mean ± s.d. P values were computed using a 
two-tailed t-test. For c, f and j, the experiments were repeated independently three 
times with similar results. Source data are provided in Supplementary Table 1. Scale 
bars, 100 μm.   
Figure 2. Derivation of porcine EPSCs. a. Left: Schematic diagram of 
establishment of the pig (Sus Scrofa) EPSCEmb lines from German Landrace day-5 in 
vivo derived blastocysts on STO feeder cells in pEPSCM, and of pEPSCiPS lines by 
reprogramming German Landrace PFFs and China TAIHU OCT4-Tdtomato knock-in 
reporter (POT) PFFs. Right panels: images of established EPSC lines, and a 
fluorescence image of Td-tomato expression in POT-pEPSCiPS. Three EPSCEmb lines 
(Male: K3 and K5; Female K1) and two pEPSCiPS lines (#10, #11) were extensively 
tested in this study. These EPSC lines behaved similarly in gene expression and 
differentiation. b. Immunostaining detection of pluripotency factors and markers, 
SSEA-1 and SSEA-4, in pEPSCEmb and pEPSCiPS. c. Bisulphite sequencing analysis 
of CpG sites in the OCT4 and NANOG promoter regions in PFFs, pEPSCiPS and 
pEPSCEmb. d. Gene expression in embryoid bodies (EBs, day 7) of pEPSCsEmb. 
Expression of genes of embryonic and extra-embryonic cell lineages were assessed by 
RT-qPCR. Relative expression levels were normalized against GAPDH. n=3 
independent experiments. Data are mean ± s.d. P values were calculated using a two-
tailed t-test. Statistical source data are provided in Supplementary table 10. e. Tissue 
composition of pEPSCEmb teratoma sections (H&E staining): Examples of glandular 
epithelium derived from endoderm (i), cartilage derived from mesoderm (ii), 
immature neural tissue derived from ectoderm, which forms neuroepithelial structures 
(iii), and large multinucleated cells reminiscent of trophoblasts (arrows in iv). f. PL-1, 
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KRT7 and SDC1 positive cells in pEPSCEmb teratoma sections as revealed by 
immunostaining. g. Detection of pEPSC descendants in the brain 
(H2BmCherry+SOX2+) and the liver (H2BmCherry+AFP+) in chimera #16. H2B-
mCherry and SOX2 are nuclear localised whereas AFP is a cytoplasmic protein. 
Boxed areas are shown in higher magnification. Arrows indicate representative cells 
that were donor cell descendants (mCherry+). DAPI stained nuclei. Additional 
chimera analyses are presented in Extended Data Fig. 3e-3f. For a-b and e-g, the 
experiments were repeated independently three times with similar results. Scale bars, 
100 μm.   
Figure 3. In vitro generation of PGC-like cells from pEPSCsEmb. a. Induction of 
pPGCLC by transiently expressing SOX17 in NANOS3-H2BmCherry reporter 
pEPSCs. The presence of H2BmCherry+TNAP+ cells in embryoid bodies (EBs) was 
analysed by FACS. The experiments were repeated independently three times with 
similar results. b. RT-qPCR analysis of PGC genes in day 3 EBs following pPGCLC 
induction. Relative expression levels werenormalized against GAPDH. n=3 
independent experiments. Data are mean ± s.d. P values were calculated using a two-
tailed t-test. Statistical source data are provided in Supplementary table 10. c. 
Immunofluorescence analysis of PGC factors in the sections of EBs at day 3-4 
following pPGCLC induction. The H2BmCherry+ cells co-expressed NANOG, 
OCT4, BLIMP1, TFAP2C and SOX17. DAPI stained nuclei. Experiments were 
performed three times. d. RNAseq analysis (Heat map) of sorted H2BmCherry+ of 
pPGCLC induction shows expression of genes associated with PGCs, pluripotency or 
somatic lineages (mesoderm, endoderm, and gonadal somatic cells). e. Pair-wise gene 
expression comparison between pEPSCsEmb and pPGCLCs. Key up-regulated (red) 
and down-regulated (blue) genes are highlighted. f. Bar plot shows expression of 
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genes related to DNA methylation in pPGCLCs and the parental pEPSCsEmb. Data 
were from RNAseq of sorted H2BmCherry+ of pPGCLC induction. Scale bars, 
100 μm.   
Figure 4. Establishment of human EPSCs. a. Images of the established H1-EPSCs 
or M1-EPSCs (passage 25). The experiments were repeated independently three times 
with similar results. b. Expression of pluripotency genes in H1-ESCs, H1-naïve ESCs 
(5i), H1-EPSCs and iPSC-EPSCs. Data are mean ± s.d. (n = 3). P values were 
computed for two-tailed t-test. c. EBs of H1-EPSCs to PGCLCs immunostained for 
SOX17, BLIMP1 and OCT4. Scale bar: 100 μm. d. Hierarchical clustering of gene 
expression (bulk RNAseq) of EPSCs, and other human pluripotent stem cells. 
Correlation matrix was clustered using Spearman correlation and complete linkage. 
Data sets are: pEPSCPar: porcine parthenogenetic EPSCs. E14 and AB2-EPSCs: 
mouse EPSCs (ref. 1); Human primed ESCs (WIBR1, iPS_NPC_4 and iPS_NPC_13) 
and naïve ESCs (WIBR2, WIBR3_cl_12, WIBR3_cl_16, WIN1_1 and WIN1_2) 
(Ref. 7 and 35); Human primed H1 ES cell (H1-rep1 and H1-rep2) and extended 
pluripotent stem (EPS) cells (H1_EPS_rep1, H1_EPS_rep2, ES1_EPS_rep1 and 
ES1_EPS_rep2) (ref. 36). e. Principal component analysis (PCA) of bulk RNA-seq 
data of EPSCs, human primed and naïve ESCs, and PFFs. Human naïve (n=5), human 
primed (n=3), H1-EPSC (n=2), hiPSC-EPSC (n=2), pEPSCEmb (n=2), pEPSCiPS 
(n=2), pEPSCPar (n=2), PFF (n=2), E14_EPSC (n=2) and AB2_EPSC (n=1). n= 
biologically independent experiments. f. Pair-wise comparison of gene expression 
between H1-ESCs and H1-EPSCs, showing the highly expressed genes (>8 folds) in 
hEPSCs (total 76, red dots) and representative histone genes (blue dots). g. Heatmap 
showing expression of selected histone genes in human ESCs, EPSCs and 
preimplantation embryos. RNAseq data of human ESCs were from ref. 35, whereas 
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embryo cell data were from ref. 37. h. RT-qPCR analysis of four histone 1 cluster 
genes in seven human ESC or iPSC lines cultured under three conditions. hiPSC lines 
were from the HIPSC project (http://www.hipsci.org): #1, HPSI1113i-bima_1; #2, 
HPSI1113i-qolg_3; #3, HPSI1113i-oaaz_2; #4, HPSI1113i-uofv_1. Relative 
expression levels are shown with normalization to GAPDH. n = 3 independent 
experiments. Data are mean ± s.d.  
*
P <0.01 compared with the FGF condition 
cultured cells. #P <0.01 compared with 5i condition cultured cells. Experiments were 
performed three times. Statistical source data and precise P values are provided in 
Supplementary table 10.  
Figure 5. Molecular features of porcine and human EPSC. a. Violin plots show 
the distribution and the probability density the scRNAseq expression of pluripotency 
genes in pEPSCsEmb (top panel, n=150) and human H1-EPSCs (lower panel, n=96). n 
represents the number of cells in each plot. b. PCA of global gene expression pattern 
(by scRNAseq) of pEPSCsEmb (left panel, n=150) and H1-EPSCs (right panel, n=96). 
n represents the number of cells in each plot. c. PCA and comparison of gene 
expression assessed by scRNAseq of human H1-EPSCs and human preimplantation 
embryos (ref. 39). H1-EPSCs (n=96), oocyte (n=3), zygote (n=3), 2 cell (n=6), 4 cell 
(n=12), 8 cell (n=20), morulae (n=16), Late blastocyst (n=30). d. ChIP-seq analysis of 
H3K27me3 and H3K4me3 marks at pluripotency gene loci in pEPSCsEmb and human 
H1-EPSCs. e. Histone modifications (H3K4me3 and H3K27me3) at the loci for genes 
encoding enzymes involved in DNA methylation and demethylation and for cell 
lineage genes.  For d and e, experiments were performed three times with similar 
results. 
Figure 6. The requirement of individual components in EPSCM. a-b. Gene 
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expression in pEPSCsEmb (a) and H1-EPSCs (b) analysed by RT-qPCR. “-SRCi, -
XAV939, -ACTIVIN, -Vc, -CHIR99”: removing individually; “+TGFBi, +H-
CHIR99, +PD03”: adding SB431542, 3.0 µM CHIR99021, or MEK1/2 inhibitor 
PD0325901, respectively. “WH04/A419”: replacing A419259 with another SRC 
inhibitor, “WH-4-23. +L-CHIR99”: 0.2 µM in hEPSCM. Porcine and human EPSC 
media contain 0.2 µM and 1.0 µM CHIR99021, respectively. Red triangle: no cell 
survived. c. Targeting the H2B-Venus cassette to the OCT4 last coding exon in H1-
EPSCs with the stop codon TGA being deleted. Five of 19 colonies genotyped were 
correctly targeted. d. The effects of removing WH-4-023 (-SRCi) or XAV939 (-
XAV) for 7 days assessed by Venus+ reporter by fluorescence microscopy and flow 
cytometry. e. Western blot analysis of AXIN1 and phosphorylation of SMAD2/3 in 
EPSCs. EPSCs had higher levels of AXIN1 and pSMAD2/3 (for TGF signalling) 
than the differentiated (D) EPSCEmb or primed H1-ESCs. f. TOPflash analysis for 
canonical Wnt signalling activity in EPSCs. Removing XAV939 (pEPSCM-X and 
hEPSCM-X) for 5 days increased TOPflash activity. g. Bright-field and 
immunofluorescence images showing pEPSCsEmb cultured with the indicated changes 
in medium component. Cells were stained for OCT4 and DAPI. h-i. Quantitation of 
AP+ colonies formed from 2,000 pEPSCsEmb (h) or H1-EPSCs (i) cultured on STO 
feeders with different medium components. The colonies were scored for 5 
consecutive passages. -ROCKi: passaging EPSCs without the ROCK inhibitor 
Y27632. j-k. RT-qPCR analysis of the expression of lineage genes in pEPSCsEmb (j) 
or hEPSCs (k) following removal of XAV939 or ACTIVIN A, inhibition of TGF 
signalling by SB431542, or treatment with 3.0 µM CHIR99021. l. The effects of 
supplementing 5.0 ng/ml ACTIVIN A on gene expression in EBs generated from H1-
EPSCs. m-n. Effects of 5.0ng/ml ACTIVIN A on PGCLC (Tdtomato+) production 
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from the NANOS3-Tdtomato reporter EPSCs assessed by FACS (m) and RT-qPCR 
(n). Relative expression levels were normalized to GAPDH. All graphs represent the 
mean ± s.d. For a-b, j-l and n, n = 3 independent experiments. For f, h-i and m, n = 4 
independent experiments. For d-e and g, the experiments were repeated independently 
three times with similar results. P values were computed by two-tailed t-test. 
Statistical source data are presented in Supplementary table 10. Scale bars: 100 μm.   
Figure 7. Trophoblast differentiation potential of hEPSCs. a. Left panel: 
differentiation of hEPSCs to trophoblasts under TGF inhibition. Right panel: flow 
cytometry analysis of trophoblast differentiation of CDX2-H2B-Venus reporter 
EPSCs, collected 4 days after TGF inhibition. The CDX2-H2B-Venus reporter 
EPSCs were also cultured in conventional FGF-containing hESCs medium or 5i-naïve 
medium and differentiated under TGF inhibition and examined by flow cytometry. 
The experiments were repeated independently three times with similar results. b. The 
dynamic changes in the expression of trophoblast genes during hEPSC differentiation 
(sampled at 2-day intervals for 12days) were assayed by RT-qPCR. Relative 
expression levels were normalized against GAPDH. n = 3 independent experiments. 
Data are mean ± s.d. *P <0.01 compared with H1-ESC cells. #P <0.01 compared with 
H1-5i cells. The precise P values are presented in Supplementary table 10. c. tSNE 
analysis of RNA-seq data of the differentiating human ESCs (n = 2) and iPSC-EPSCs 
(n = 4) treated with TGF inhibitor SB431542. RNAs were sampled from cells at Day 
0-12 of differentiation. The of H1-EPSCs and hiPSC-EPSCs showed different 
trajectory of differentiation from H1-ESCs. d. Heatmap shows changes in the 
expression of trophoblast-specific genes in differentiating H1-ESCs (green), H1-
EPSCs (red) and iPSC-EPSCs (blue) collected at several time points of culture for 
RNAseq analysis. e. DNA demethylation at the promoter region of the ELF5 locus in 
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differentiating  H1-EPSCs and other cell types following 6 days of SB431542 
treatment. Cells from H1-ESCs, H1-naïve ESCs (5i) showed no discernible DNA 
demethylation at the ELF5 promoter. f. Secreted hormones from trophoblasts derived 
from H1-EPSCs induced by TGF inhibition (SB431542). VEGF, PLGF, sFlt-1and 
sEng were measured in the conditioned media for culturing the differentiating EPSCs 
or ESCs for 16 days following a 48-h SB431542 treatment.  g. hCG produced by 
trophoblasts from SB431542-treated EPSCs or ESCs at day 10 of differentiation, 
measured by ELISA. n = 4 independent experiments. Data are mean ± s.d. P values 
were calculated using a two-tailed t-test. Statistical source data are presented in 
Supplementary table 10. 
Figure 8. Derivation of trophoblast stem cell-like cells from hEPSCs. a. Phase-
contrast images of primary TSC colonies formed from individual hEPSCs (left) and 
of TSCs at passage 7 (right). b. Expression of trophoblast markers GATA3,  TFAP2C 
and KRT7 in EPSC-TSCs detected by immunostaining. Nuclei were stained with 
DAPI. Similar results were obtained with four independent EPSC-TSC lines. c. RT-
qPCR analysis of pluripotency and TSC genes in four EPSC-derived TSC lines and 
their parental hEPSCs. JEG3 and JAR are trophoblast cell lines. n = 3 independent 
experiments. Data are mean ± s.d.. *p < 0.01 compared to TSCs.  The precise P 
values are presented in Supplementary table 10. d. PCA of gene expression of hTSCs 
(n = 3) and of cells differentiated from human EPSCs (n = 2) under TGF inhibition 
at several time points. hTSCs showed enriched transcriptomic features of day-4 
differentiated EPSCs. e. Immunostaining of SDC1 and CGB in hTSC-dervied 
syncytiotrophoblasts. DAPI stained the nucleus. f. Phase-contrast and Hoechst 
staining images of multinucleated hTSC-derived syncytiotrophoblasts. g. The fusion 
index of forming syncytiotrophoblasts from hTSCs calculated as the number of nuclei 
 30 
in syncytia/total number of nuclei. n = 4 independent experiments. Data are mean ± 
s.d. h. RT-qPCR analysis of trophoblast-specific genes in syncytiotrophoblast (ST) 
and extravillous trophoblast (EVT) derived from three hTSC lines. Expression levels 
were normalized against GAPDH. n = 3 independent experiments. Data are mean ± 
s.d. i. Flow cytometry detection of HLA-ABC and HLA-G in hESCs, hEPSCs, 
hTSCs, and hTSC-derived EVT cells (protocol of ref. 46). The choriocarcinoma cells 
JEG-3 and JAR represent the extravillous and villous trophoblast cells, respectively. 
JEG-3 cells expressed HLA-G, HLA-C and HLA-E, but not JAR cells. j. H&E 
staining of lesions formed by hTSCs engrafted subcutaneously in NOD-SCID mice. 
k. Confocal images of immunostaining for SDC1- or KRT7-positive cells in hTSC-
derived lesions. DAPI stained the nucleus.  l. Serum hCG levels in six NOD-SCID 
mice 7 days after hTSC engraftment (n = 3) or injection of vehicle only (n = 3). For a-
b, e-f and h-l, the experiments were repeated independently three times with similar 
results. Statistical source data are presented in Supplementary table 10. Scale bars: 

























Supplementary Figure 1 
Culture condition screening for porcine EPSC 
a-g. The relative expression levels of endogenous OCT4 and NANOG in the survived cells after 6 days of 
culture in different basal media supplemented with inhibitors and cytokines combinations: a. M15 medium 
without Dox; b. N2B27 basal medium without Dox; c. 20% KOSR medium without Dox; d. AlbumMax II 
basal medium without Dox; e. N2B27 basal medium with Dox; f. Four individual basal media with Dox (M15: 
411-431; N2B27: 432-453; KOSR: 454-475; AlbumMax II: 476-497); g. N2B27 basal medium without Dox. 
2i: GSK3i and MEKi; t2i: GSK3i, MEKi and PKCi (Takashima, Y., et al. 2014 Cell); 4i: GSK3i, MEKi, JNKi 
and p38i (Irie, N., et al 2015 Cell); 5i: GSK3i, MEKi, ROCKi, BRAFi and SRCi (Theunissen, T. W., et al. 2014 
Cell Stem Cell); mEPSCM: GSK3i, MEKi, JNKi, XAV939, SRCi and p38i (Yang J., et al. 2017 Nature); 
Details of the inhibitor combinations are presented in Supplementary Table 1. Relative expression levels were 
normalized to GAPDH. h. Images showing the toxicity of MEKi, PKCi and p38i to the porcine iPSCs in M15 
plus Dox. i. Endogenous pluripotency gene expression in porcine iPSCs in the absence of Dox in pEPSCM 
(#517 minimal condition, Extended Data Fig. 2h). Gene expression was compared to that of porcine blastocysts. 
n = 3 independent experiments. Data are mean ± s.d. j. Detection of expression of the exogenous 
reprogramming factors by RT-PCR showed no detectable leaky expression in about half of the iPSC lines. For 
h and j, the experiments were repeated independently three times with similar results. Statistical source data are 






Supplementary Figure 2 
Establishment of porcine EPSCs by reprogramming PFFs or from pre-implantation embryos 
a. Schematic diagram of reprogramming PFFs to establish EPSC lines in pEPSCM. b. Two WT pEPSCiPS lines 
(#10 and #11) were examined for expression of endogenous pluripotency genes and the exogenous 
reprogramming factors.  n= 3 independent experiments. Data are mean ± s.d. c. Day-10 outgrowth from a 
porcine early blastocyst in pEPSCM supplemented with a ROCK inhibitor. The outgrowths were picked at day 
10-12 for dissociation and re-plating to establish stable lines. d. Representative images of the pEPSCEmb (Line 
K3) established from pig in vivo derived embryos. Experiments were performed at least three times. e. 
pEPSCEmb (Line K3) retained a normal karyotype after 25 passages (10/10 metaphase spreads examined were 
normal). Two additional lines examined also maintained the normal karyotype after more than 25 passages. f-g. 
pEPSCs were cultured under seven previously reported porcine ESCs conditions for 7 days, and cell 
morphology and gene expression were examined. f. Immunofluorescence staining for OCT4 expression. g. RT-
qPCR detection of OCT4 and NANOG in pEPSCs. n = 3 independent experiments. Data are mean ± s.d. h. 
Active Oct4 distal enhancer in porcine EPSCEmb and EPSCiPS. The mouse Oct4 distal and proximal enhancer 
constructs were used in the luciferase assay. n = 4 independent experiments. Data are mean ± s.d. i. Genome-
editing in pEPSCsEmb: Knocking-in the H2B-mCherry expressing cassette into pig ROSA26 locus by 
Crispr/Cas9. 5 out 20 colonies picked for genotyping were correctly targeted and retained a normal karyotype. j. 
Bright field and fluorescence images of the pEPSCEmb colonies with the H2B-mCherry correctly targeted to the 
ROSA26 locus. k. in vitro differentiation of pEPSCEmb to cells of the germ layers and the trophectoderm lineage 
(KRT7+). Relative expression levels were normalized to GAPDH. For c, f and i-k, the experiments were 
repeated independently three times with similar results. Statistical source data are provided in Supplementary 







Supplementary Figure 3 
In vivo differentiation potential of pEPSCs 
a. Participation of pEPSCs in preimplantation embryo development. H2B-mCherry-expressing donor 
pEPSCsiPS were injected into day 5 host pig parthenogenetic embryos, which developed to blastocysts. 
H2BmCherry+ donor cells were found in both the inner cell mass and the trophectoderm (arrowed). Scale bar: 
50 μm. The experiments were repeated independently three times with similar results. b. Whole-mount 
fluorescence and bright field images of 27-day pig conceptuses derived from preimplantation embryos injected 
with H2BmCherry+ pEPSCsEmb, showing mCherry+ cells in chimera #21. Scale bar: 1.0 cm. c. Chimeras were 
processed with half of which were fixed for immunofluorescence analysis, and the other half for FACS and 
DNA genotyping. To prepare cells for FACS analysis, tissues of each embryo were isolated from head (a), 
trunk (b), tail (c), and the placenta (d), and were dissociated to single cells and selected for donor H2BmCherry+ 
cells. The dissociated cells were also used for preparing genomic DNA samples for PCR analysis. d. PCR 
genotyping for mCherry DNA using the genomic DNA samples. mCherry DNA was detected only in the 
embryos that were mCherry+ by flow cytometry analysis. e. Schematic diagram of day 26-28 pig chimera 
conceptuses. The circles mark the tissue areas where tissue sections were taken for immunostaining and 
imaging shown in (f). f. Immunofluorescence analysis of cryosections of day 26-28 mCherry+ conceptuses or 
chimeric embryos and placentas for H2BmCherry+ cells in different tissues. The antibodies used include TUJ1 
for neurons (Chimera #16); SOX17 and GATA4 for endodermal derivatives (Chimera #21); a-SMA for 
mesodermal derivatives (Chimera #21); PL-1 and KRT7 for trophoblasts (placenta of Chimera #6). 
H2BmCherry, GATA4 and SOX17 were found in the nucleus, whereas TUJ, A-SMA, KRT7 and PL-1 were not 
nuclear localised. For b-d and f, the experiments were repeated independently three times with similar results. 







Supplementary Figure 4 
Differentiation of pEPSCs to pPGCLCs 
a. Generation of the NANOS3-H2BmCherry reporter EPSCsEmb by targeting the H2B-mCherry cassette to the 
NANOS3 locus. In the targeted allele, the T2A-H2B-mCherry sequence was in frame with the last coding exon 
of the pig NANOS3 locus with the stop codon TAA being deleted. We generated gRNA plasmids targeting 
specifically to the region covering the NANOS3 stop codon, and 4 out 15 colonies picked for genotyping were 
correctly targeted. After expansion, those targeted pEPSCs retained a normal karyotype. b. Diagram illustrating 
the strategy for expressing exogenous genes in pEPSCsEmb for pPGCLC specification and differentiation (see 
Methods for details). c. Expression of NANOG, BLIMP1 and TFAP2C individually or in combination with 
SOX17 in the pPGCLCs (H2BmCherry+) in EBs differentiation from NANOS3-H2BmCherry reporter 
EPSCsEmb. Scale bars: 100 μm. d. Quantitation of NANOS3-H2BmCherry positive cells in (c). n = 4 
independent experiments. Data are mean ± s.d. P values were calculated using a two-tailed t-test. e. RT-qPCR 
analysis of PGC genes. RNA samples were prepared from day 3 EBs of pEPSCs that expressed transgenes 
individually or in combinations following the pPGCLC induction protocol in b. Expression levels were 
normalized to GAPDH. n = 3 independent experiments. Data are mean ± s.d.. Statistical source data are 







Supplementary Figure 5 
Establishment and characterisation of human EPSCs 
a. Images of H1, H9, M1 and M10 human ESC colonies in pEPSCM or in pEPSCM without ACTIVIN A. 
Expression of OCT4 was detected by immunostaining. b. Normal karyotype in H1-EPSCs and M1-EPSCs after 
25 passages in hEPSCM (10/10 metaphases scored were normal). c. Primary iPSC colony (top) and established 
cultures of iPSCs (bottom) in hEPSCM reprogrammed from human fibroblasts by Dox-inducible expression of 
exogenous OCT4, MYC, KLF4, SOX2, LRH1 and RARG. d. Analysis of the expression of the exogenous 
reprogramming factors by RT-qPCR revealed no obvious leaky expression in four established iPSC lines. e. 
The relative population doubling time of H1-ESCs, H1-naïve ESCs (5i), H1-EPSCs and iPSC-EPSCs. n = 4 
independent experiments. Data are mean ± s.d. P values were calculated using a two-tailed t-test. f. Expression 
of lineage markers (EOMES, GATA4, GATA6, T, SOX17 and RUNX1) in H1-ESCs, H1-naïve ESCs (5i), H1-
EPSCs and iPSC-EPSCs. n = 3 independent experiments. Data are mean ± s.d. P values were calculated 
between H1-ESCa and H1-EPSCs using a two-tailed t-test g. Immunostaining of H1-EPSCs and iPSC-EPSCs 
for pluripotency factors and cell surface markers. h. In vitro differentiation of H1-EPSCs to the germ layer 
lineages. i. The presence of cartilage (mesoderm. I), glandular epithelium (endoderm. II) and mature neural 
tissue (glia and neurons, ectoderm. III) in teratomas derived from hEPSCs. H&E staining.  j. FACS analysis for 
expression of CD38 and TNAP on PGCLCs of H1-EPSCs. The induction of PGCLCs was performed on at least 
two human EPSC lines. Relative expression levels were normalized to GAPDH. For a, c-d and g-j, the 
experiments were repeated independently three times with similar results. Statistical source data are presented 







Supplementary Figure 6 
RNAseq analysis of human and porcine EPSC transcriptome 
a-b. Expression of pluripotency and lineage genes in porcine (a) or human (b) EPSCs. c-d. Expression of 
trophoblast related genes in porcine (c) or human (d) EPSCs. e. Global DNA methylation levels in porcine and 
human EPSCs. H1-5i human naïve ESCs was included in the analysis. n = 3 independent experiments. Data are 
mean ± s.d. *p < 0.01, comparison of H1-5i human naïve ESCs with H1-ESCs and H1-EPSCs. The P values 
were computed by two-tailed t-test and are presented in Supplementary table 10. f-g. RNAseq analysis of 
expression of genes encoding enzymes for DNA methylation or demethylation in porcine (f) and human (g) 
EPSCs. h. PCA of scRNAseq data of human H1-EPSCs and that of human preimplantation embryos (data from 
ref. 38). H1-EPSCs (lower panel, n=96), Oocyte (n=4), Zygote (n=5), 2c-ell (n=4), 4-cell (n=4), 8-cell (n=4), 
Morula (n=4), ICM (n=3), EarlyBlastocyst (n=3), MiddleBlastocyst (n=3), LateBlastocyst (n=3), TE (n=3). i. 
Violin plots of the expression levels of histone genes in human EPSCs (this study) and in human 
preimplantation embryos at various dvelopemntal stages (ref.38). H1-EPSCs (n=96), Oocyte (n=3), zygote 
(n=3), 2-cell (n=6), 4-cell (n=12), 8-cell (n=20), morulae (n=16), Late blastocyst (n=30). Gene expression 
(TPM) was quantified by salmon and the values of log10(TPM + 1). Gene expression level in individual cells 







Supplementary Figure 7 
Trophoblast differentiation of hEPSCs 
a. Generation of the CDX2-H2BVenus reporter EPSC line where the T2A-H2BVenus was in frame with the last 
coding exon of CDX2 gene with the TGA stop codon being deleted. The reporter EPSCs were subsequently 
cultured in hEPSCM, the FGF-containing ESC medium or in the 5i condition for subsequent analyses. b-c. 
Expression of trophoblast-related genes analyzed by RT-qPCR of trophoblasts produced after 4-day BMP4 
treatment (b) or by SB431542+PD173074+BMP4 sampled at several time points (c). Relative expression levels 
were normalized to GAPDH. *p < 0.01 compared with H1-ESCs and H1-5i naïve cells. n = 3 independent 
experiments. Data are mean ± s.d. The precise P values were computed by two-tailed t-test and are presented in 
Supplementary table 10. d. Pearson correlation coefficient of gene expression in cells differentiated from H1-
ESCs, H1-EPSCs and iPSC-EPSCs, incorporating published data (ref. 43) of primary human undifferentiated 
(PHTu) and differentiated trophoblasts (PHTd), and human tissues. e. C19MC miRNAs in EPSCs or ESCs 
treated with SB431542 for six days. JEG-3 and JAR represent extravillous trophoblasts and villous trophoblast 
cells, respectively. f. Expression of the same miRNAs in the BMP4 (4-day) treated EPSCs and ESCs. *p < 0.05 
compared with H1-ESCs. n = 3 independent experiments. Data are mean ± s.d. The precise P values were 
computed by two-tailed t-test and are provided in Supplementary table 10.  miRNA expression levels are 
normalized to miR-103a. g. CRISPR/Cas9 mediated deletion of ~350bp in PARG exon 4 using two gRNAs (g1, 
g2) in CDX2-H2BVenus reporter hEPSCs. 6 out of 48 clones picked were bi-allelic mutants by PCR and 
sequencing. h. Trophoblast differentiation of PARG homozygous deletion CDX2-reporter EPSC cells (PARG-/-) 
under TGF inhibition for four days and analysed by flow cytometry. The experiments were repeated 
independently four times with similar results. i. The percentages of Venus+ cells as in (h). n = 4 independent 
experiments. Data are mean ± s.d. P values were computed by two-tailed t-test. Similar results were obtained 
using two independent PARG-/- hEPSC lines. j. RT-qPCR analysis of trophoblast genes in WT or PARG-/- H1-
 
 
EPSCs after 6 days of SB431542 treatment. n = 3 independent experiments. Data are mean ± s.d. P values were 
computed by two-tailed t-test. Expression levels are normalized to GAPDH. Statistical source data are presented 







Supplementary Figure 8 
Derivation and characterisation of trophoblast stem cell-like cells (pTSCs) from porcine EPSCs 
a. H3K27me3 and H3K4me3 marks at the loci encoding factors associated with placenta development in 
pEPSCEmb and human H1-EPSCs. b. Images of primary TSC colonies (top) formed from individual pEPSCEmb 
on day 7 cultured in human TSC condition, and of established pTSCs at passage 7 (bottom). Dashed lines mark 
the area of putative trophoblasts, which were picked for establishing stable pTSC lines. c. RT-qPCR analysis of 
pluripotency and trophoblast genes in four pTSC lines and their parental pEPSCEmb. n = 3 independent 
experiments. Data are mean ± s.d. *p < 0.01 comparison between pEPSCs to pTSCs. P values were computed 
by two-tailed t-test and provided in Supplementary table 10. Expression levels are normalized to GAPDH. d. 
Expression of trophoblast factors GATA3 and KRT7 in pTSCs detected by immunostaining. DAPI stained 
nuclei. e. Confocal image of immunostaining of sections of lesions formed by pTSCs in NOD-SCID mice for 
cells expressing SDC1 and KRT7. f. Histology of the pTSC-derived lesions. H&E staining. g. Confocal images 
of immunostaining of porcine blastocysts 1 to 2 days following injection of H2B-mCherry-expressing pTSCs 
into porcine parthenogenetic or IVF morulae and early blastocysts (n = 50 blastocysts in two injections). Arrow 
indicates H2B-mCherry+ cells in the trophectoderm which expressed the porcine trophectoderm transcription 
factor GATA3 and CDX2. For a-b and d-g, the experiments were repeated independently three times with 
similar results. Statistical source data are presented in Supplementary table 10. Scale bars: 100 μm.   
 
 
